All AbMole products are for research use only, cannot be used for human consumption.
Saralasin TFA is an octapeptide analog of Angiotensin II and a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM (74% of binding sites) and partial agonist activity. It has a Ki value of 0.32 nM (74% of binding sites) and partial agonist activity. It can be used in studies related to renal vascular hypertension and renin-dependent (angiotensinogenic) hypertension.
| Molecular Weight | 1026.07 |
| Formula | C44H66F3N13O12 |
| CAS Number | 34273-10-4 (free base) |
| Form | Solid |
| Solubility (25°C) | Water 100 mg/mL DMSO 50 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Angiotensin Receptor Products |
|---|
| Azilsartan medoxomil
Azilsartan Medoxomil is an effective angiotensin II Type 1 (AT1) receptor antagonist that inhibits RAAS more than 10,000 times more selectively than AT2, and is used to study hypertension. |
| Azilsartan
Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. |
| PD 123319 ditrifluoroacetate
PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist. |
| Losartan potassium
Losartan potassium is a selective non-peptide angiotensin AT1 receptor antagonist. |
| Eprosartan Mesylate
Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
